Patent 7169897 was granted and assigned to ZymoGenetics on January, 2007 by the United States Patent and Trademark Office.
Novel zacrp3x2 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. Also disclosed are antibodies to the zacrp3x2 protein or fragments thereof.